ICICI Prudential Nifty Pharma Index Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 23-03-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY PHARMA - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -6.98 27.09 15.17 2.00 4,267.60
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 -1.95 27.89 12.84 2.20 1,574.52
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 -9.42 24.15 11.47 2.54 655.16
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 -8.42 23.50 13.64 2.44 485.91

Fund Holdings as on 28-February-2023

  • Sun Pharmaceutical Industries Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Cipla Ltd.

  • Divi's Laboratories Ltd.

  • Lupin Ltd.

  • Alkem Laboratories Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Aurobindo Pharma Ltd.

  • Laurus Labs Ltd.

  • Zydus Lifesciences Ltd.

  • IPCA Laboratories Ltd.

  • Abbott India Ltd.

  • Biocon Ltd.

  • TREPS

  • Gland Pharma Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Pfizer Ltd.

  • Glaxosmithkline Pharmaceuticals Ltd.

  • Sanofi India Ltd.

  • Natco Pharma Ltd.

  • Granules India Ltd.

  • Net Current Assets

View More
  • Pharmaceuticals & Drugs

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About ICICI Prudential Nifty Pharma Index Fund

Scheme Analysis

ICICI Prudential Nifty Pharma Index Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 14-Dec-2022 and currently has an AUM of ₹11.18 crore. ICICI Prudential Nifty Pharma Index Fund is benchmarked against NIFTY PHARMA - TRI as primary index.

The NAV of ICICI Prudential Nifty Pharma Index Fund ended up ₹0.02(0.22%)yesterday to ₹9.1445.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The ICICI Prudential Nifty Pharma Index Fund is managed by Kayzad Eghlim and Nishit Patel.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100